Who is sponsoring NCT04919317?

NCT04919317 is sponsored by Temple University.

What condition does NCT04919317 study?

NCT04919317 studies Pain, Postoperative, Mammaplasty.

What drugs are being tested in NCT04919317?

Interventions: Dexamethasone 4mg, Saline.

What is the status of NCT04919317?

NCT04919317 is currently COMPLETED.

Last reviewed 2023-10-11 · How we verify

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

NCT04919317 PHASE2 COMPLETED Results posted

The addition of dexamethasone to non-liposomal bupivacaine in perineural blocks has been shown to enhance pain control and prolong the time until first request for postoperative narcotics in the fields of orthopedic, thoracic, and gynecologic surgery. This has not been investigated in any types of breast surgery. The investigators assessed if the combination of dexamethasone to bupivacaine in the preoperative field block prior to bilateral breast reduction surgery resulted in improved pain control relative to bupivacaine alone.

Details

Lead sponsor	Temple University
Phase	PHASE2
Status	COMPLETED
Enrolment	56
Start date	Fri Sep 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Nov 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pain, Postoperative
Mammaplasty

Interventions

Dexamethasone 4mg
Saline

Countries

United States